{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:33:06Z","timestamp":1761931986255,"version":"build-2065373602"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,12,1]],"date-time":"1997-12-01T00:00:00Z","timestamp":880934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[1997,12]]},"DOI":"10.1023\/a:1025777700413","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T18:33:40Z","timestamp":1067020420000},"page":"673-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Physiological Indirect Effect Modeling of the Antilipolytic Effects of Adenosine A1-Receptor Agonists"],"prefix":"10.1007","volume":"25","author":[{"given":"Erno A.","family":"van Schaick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik J. M. M.","family":"de Greef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan P.","family":"Ijzerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meindert","family":"Danhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1997,12,1]]},"reference":[{"key":"424760_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ddr.430280346","volume":"28","author":"M. Williams","year":"1993","unstructured":"M. Williams. Purinergic drugs: opportunities in the 1990s. Drug Dev. Res.\n28:438\u2013444 (1993).","journal-title":"Drug Dev. Res."},{"key":"424760_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/ddr.430320209","volume":"32","author":"J. E. Foley","year":"1994","unstructured":"J. E. Foley. Rationale for activation of adenosine A1 receptors in adipocytes in the treatment of non-insulin dependent diabetes mellitus. Drug. Dev. Res.\n32:126 (1994).","journal-title":"Drug. Dev. Res."},{"key":"424760_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1021\/jm00081a001","volume":"35","author":"K. A. Jacobson","year":"1992","unstructured":"K. A. Jacobson, P. J. M. van Galen, and M. Williams. Adenosine receptors: Pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem.\n35:407\u2013422 (1992).","journal-title":"J. Med. Chem."},{"key":"424760_CR4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0022-3565(25)38981-0","volume":"268","author":"R. A. A. Math\u00f4t","year":"1994","unstructured":"R. A. A. Math\u00f4t, E. A. van Schaick, M. W. E. Langemeijer, W. Soudijn, D. D. Breimer, A. P. IJzerman, and M. Danhof. Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N\n6-cyclopentyladenosine in the rat. J. Pharmacol. Exp. Ther.\n268:616\u2013624 (1994).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"424760_CR5","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1111\/j.1476-5381.1995.tb16398.x","volume":"116","author":"R. A. A. Math\u00f4t","year":"1995","unstructured":"R. A. A. Math\u00f4t, E. M. van der Wenden, W. Soudijn, A. P. IJzerman, and M. Danhof. Deoxyribose analogues of N\n6-cyclopentyladenosine (CPA): Partial agonists at the adenosine A1 receptor in vivo. Br. J. Pharmacol.\n116:1957\u20131964 (1995).","journal-title":"Br. J. Pharmacol."},{"key":"424760_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bjp.0701412","volume":"122","author":"E. A. van Schaick","year":"1997","unstructured":"E. A. van Schaick, H. J. M. M. de Greef, M. W. E. Langemeijer, M. J. Sheehan, A. P. IJzerman, and M. Danhof. Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N\n6-(p-sulfophenyl) adenosine in rats. Br. J. Pharmacol.\n122:525\u2013533, 1997.","journal-title":"Br. J. Pharmacol."},{"key":"424760_CR7","first-page":"785","volume":"1","author":"P. J. Randle","year":"1969","unstructured":"P. J. Randle, C. N. Hales, P. B. Garland, and E. A. Newsholme. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances in diabetes mellitus. Lancet\n1:785\u2013789 (1969).","journal-title":"Lancet"},{"key":"424760_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0002-9343(88)90402-0","volume":"85","author":"G. M. Reaven","year":"1988","unstructured":"G. M. Reaven and Y-D. I. Chen. Role of abnormal free fatty acid metabolism in the development of non-insulin dependent diabetes mellitus. Am. J. Med.\n85:106\u2013112 (1988).","journal-title":"Am. J. Med."},{"key":"424760_CR9","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1126\/science.1439783","volume":"258","author":"J. D. McGarry","year":"1992","unstructured":"J. D. McGarry. What if Minkowski had been ageusic? An alternative angle on diabetes. Science\n258:766\u2013770 (1992).","journal-title":"Science"},{"key":"424760_CR10","doi-asserted-by":"crossref","first-page":"15139","DOI":"10.1016\/S0021-9258(18)95713-3","volume":"260","author":"C. Londos","year":"1985","unstructured":"C. Londos, R. C. Honner, and G. S. Dhillon. c-AMP dependent protein kinase and lipolysis in rat adipocytes. III. Multiple modes of insulin regulation of lipolysis and regulation of insulin responses by adenylate cyclase. J. Biol. Chem.\n260:15139\u201315145 (1985).","journal-title":"J. Biol. Chem."},{"key":"424760_CR11","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1021\/jm00100a020","volume":"35","author":"K. A. Jacobson","year":"1992","unstructured":"K. A. Jacobson, O. Nikodijevi, X. Ji, D. A. Berkich, D. Eveleth, R. L. Dean, K. Hiramatsu, N. F. Kassel, P. J. M. van Galen, K. S. Lee, R. T. Bartus, J. W. Daly, K. F. LaNoue, and M. Maillard. Synthesis and biological activity of N\n6-(p-sulfophenyl)alkyl and N\n6-sulfoalkyl derivatives of adenosine: Water-soluble and peripherally selective adenosine agonists. J. Med. Chem.\n35:4143\u20134149 (1992).","journal-title":"J. Med. Chem."},{"key":"424760_CR12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1982","unstructured":"M. Gibaldi and D. Perrier. Non-compartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982, pp. 409\u2013424.","edition":"2nd ed."},{"key":"424760_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01117450","volume":"6","author":"K. Yamoaka","year":"1978","unstructured":"K. Yamoaka, T. Nakagawa, and T. Uno. Application of Aikaike's information criterion (AIC) in the evaluation of linear pharmacokinetics. J. Pharmacokin. Biopharm.\n6:165\u2013175 (1978).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"424760_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/BF01061691","volume":"21","author":"N. L. Dayneka","year":"1993","unstructured":"N. L. Dayneka, V. Garg, and J. W. Jusko. Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokin. Biopharm.\n21:457\u2013478 (1993).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"424760_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF01062199","volume":"18","author":"A. I. Nichols","year":"1990","unstructured":"A. I. Nichols and W. J. Jusko. Receptor-mediated prednisolone pharmacodynamics in rats: verification using a dose-sparing regimen. J. Pharmacokin. Biopharm.\n18:189\u2013208 (1990).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"424760_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/clpt.1991.66","volume":"49","author":"S. K. Yamashita","year":"1991","unstructured":"S. K. Yamashita, E. A. Ludwig, E. Middleton, and J. W. Jusko. Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone. Clin. Pharmacol. Ther.\n49:558\u2013570 (1991).","journal-title":"Clin. Pharmacol. Ther."},{"key":"424760_CR17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0022-3565(25)22848-8","volume":"250","author":"A. I. Nichols","year":"1989","unstructured":"A. I. Nichols, R. D'Ambrosio, N. A. Pyszcynski, and J. W. Jusko. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats. J. Pharmacol. Exp. Ther.\n250:963\u2013970 (1989).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"424760_CR18","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/0009-9236(95)90019-5","volume":"58","author":"J. M. T. van Griensven","year":"1995","unstructured":"J. M. T. van Griensven, J. W. Jusko, H. H. P. J. Lemkes, R. Kroon, C. J. Verhorst, S. T. Chiang, and A. F. Cohen. Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes. Clin. Pharmacol. Ther.\n58: 631\u2013640 (1995).","journal-title":"Clin. Pharmacol. Ther."},{"key":"424760_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF00501186","volume":"276","author":"U. Schwabe","year":"1973","unstructured":"U. Schwabe, R. Ebert, and H. C. Erbler. Adenosine release from isolated fat cells and its significance for the effects of hormones on cyclic 3\u2032,5\u2032-AMP levels and lipolysis. Naunyn-Schmeidebergs Arch. Exp. Pathol. Pharmakol.\n276:133\u2013148 (1973).","journal-title":"Naunyn-Schmeidebergs Arch. Exp. Pathol. Pharmakol."},{"key":"424760_CR20","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/clpt.1994.155","volume":"56","author":"W. J. Jusko","year":"1994","unstructured":"W. J. Jusko and H. C. Ko. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin. Pharmacol. Ther.\n56:406\u2013419 (1994).","journal-title":"Clin. Pharmacol. Ther."},{"key":"424760_CR21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/cs0900243","volume":"90","author":"K. N. Frayn","year":"1996","unstructured":"K. N. Frayn, C. M. Williams, and P. Arner. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin. Sci.\n90:243\u2013253 (1996).","journal-title":"Clin. Sci."},{"key":"424760_CR22","first-page":"9","volume":"2","author":"R. H. Ackermann","year":"1975","unstructured":"R. H. Ackermann, K. H. B\u00e4ssler, and K. Wagner. Glyzerin: Ausnutzung, Umsatzkapazit\u00e4t und biokinetische Daten unter intraven\u00f6ser Zufuhr bei der Ratte. Infusionstherapie\n2:9\u201315 (1975).","journal-title":"Infusionstherapie"},{"key":"424760_CR23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1042\/cs0840663","volume":"84","author":"P. Strong","year":"1993","unstructured":"P. Strong, R. Anderson, J. Coates, F. Ellis, B. Evans, M. F. Gurden, J. Johnstone, I. Kennedy, and D. P. Martin. Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236. Clin. Sci.\n84:663\u2013669 (1993).","journal-title":"Clin. Sci."},{"key":"424760_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0014-2999(94)90702-1","volume":"257","author":"C. J. Gardner","year":"1994","unstructured":"C. J. Gardner, D. J. Twissell, J. Coates, and P. Strong. The effects of GR79236 on plasma fatty acid concentrations, heart rate and blood pressure in the conscious rat. Eur. J. Pharmacol.\n257:117\u2013121 (1994).","journal-title":"Eur. J. Pharmacol."},{"key":"424760_CR25","first-page":"E23","volume":"254","author":"G. M. Reaven","year":"1988","unstructured":"G. M. Reaven, H. Chang, H. Ho, C. I. Jeng, and B. Hoffman. Lowering of plasma glucose in diabetic rats by antilipolytic agents. Am. J. Physiol.\n254:E23\u201330 (1988).","journal-title":"Am. J. Physiol."},{"key":"424760_CR26","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/0165-6147(93)90094-Z","volume":"14","author":"M. G. Collis","year":"1993","unstructured":"M. G. Collis and S. M. O. Hourani. Adenosine receptor subtypes. Trends Pharmacol. Sci.\n14:360\u2013366 (1993).","journal-title":"Trends Pharmacol. Sci."},{"key":"424760_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/clpt.1992.47","volume":"51","author":"C. C. Peck","year":"1992","unstructured":"C. C. Peck, W. H. Barr, L. Z. Benet, J. Collins, R. E. Desjardins, D. E. Furst, J. G. Harter, G. Levy, T. Ludden, J. H. Rodman, L. Sanathan, J. J. Schentag, V. P. Shah, L. B. Sheiner, J. P. Kelly, D. R. Stanski, R. J. Temple, C. T. Viswanathan, J. Weissinger, and A. Yacobi. Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. Clin. Pharmacol. Ther.\n51:465\u2013473 (1992).","journal-title":"Clin. Pharmacol. Ther."},{"key":"424760_CR28","first-page":"267","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1975","unstructured":"M. Gibaldi and D. Perrier. Method of Laplace transforms. In Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1975, pp. 267\u2013272.","edition":"2nd ed."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025777700413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1025777700413\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025777700413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T09:46:39Z","timestamp":1751622399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1025777700413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,12]]}},"alternative-id":["424760"],"URL":"https:\/\/doi.org\/10.1023\/a:1025777700413","relation":{},"ISSN":["0090-466X"],"issn-type":[{"type":"print","value":"0090-466X"}],"subject":[],"published":{"date-parts":[[1997,12]]},"assertion":[{"value":"1 December 1997","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}